167 related articles for article (PubMed ID: 35408990)
1. CD33 rs2455069 SNP: Correlation with Alzheimer's Disease and Hypothesis of Functional Role.
Tortora F; Rendina A; Angiolillo A; Di Costanzo A; Aniello F; Donizetti A; Febbraio F; Vitale E
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408990
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of CD33 as a genetic risk factor for Alzheimer's disease.
Estus S; Shaw BC; Devanney N; Katsumata Y; Press EE; Fardo DW
Acta Neuropathol; 2019 Aug; 138(2):187-199. PubMed ID: 30949760
[TBL] [Abstract][Full Text] [Related]
3. CD33 Alzheimer's risk-altering polymorphism, CD33 expression, and exon 2 splicing.
Malik M; Simpson JF; Parikh I; Wilfred BR; Fardo DW; Nelson PT; Estus S
J Neurosci; 2013 Aug; 33(33):13320-5. PubMed ID: 23946390
[TBL] [Abstract][Full Text] [Related]
4. Human brain sialoglycan ligand for CD33, a microglial inhibitory Siglec implicated in Alzheimer's disease.
Gonzalez-Gil A; Porell RN; Fernandes SM; Maenpaa E; Li TA; Li T; Wong PC; Aoki K; Tiemeyer M; Yu ZJ; Orsburn BC; Bumpus NN; Matthews RT; Schnaar RL
J Biol Chem; 2022 Jun; 298(6):101960. PubMed ID: 35452678
[TBL] [Abstract][Full Text] [Related]
5. CD33 and SIGLECL1 Immunoglobulin Superfamily Involved in Dementia.
Rendina A; Drongitis D; Donizetti A; Fucci L; Milan G; Tripodi F; Giustezza F; Postiglione A; Pappatà S; Ferrari R; Bossù P; Angiolillo A; di Costanzo A; Caiazzo M; Vitale E
J Neuropathol Exp Neurol; 2020 Aug; 79(8):891-901. PubMed ID: 32647856
[TBL] [Abstract][Full Text] [Related]
6. Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortex.
Walker DG; Whetzel AM; Serrano G; Sue LI; Beach TG; Lue LF
Neurobiol Aging; 2015 Feb; 36(2):571-82. PubMed ID: 25448602
[TBL] [Abstract][Full Text] [Related]
7. CD33 in Alzheimer's disease.
Jiang T; Yu JT; Hu N; Tan MS; Zhu XC; Tan L
Mol Neurobiol; 2014 Feb; 49(1):529-35. PubMed ID: 23982747
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta.
Griciuc A; Serrano-Pozo A; Parrado AR; Lesinski AN; Asselin CN; Mullin K; Hooli B; Choi SH; Hyman BT; Tanzi RE
Neuron; 2013 May; 78(4):631-43. PubMed ID: 23623698
[TBL] [Abstract][Full Text] [Related]
9. Deletion of Alzheimer's disease-associated CD33 results in an inflammatory human microglia phenotype.
Wißfeld J; Nozaki I; Mathews M; Raschka T; Ebeling C; Hornung V; Brüstle O; Neumann H
Glia; 2021 Jun; 69(6):1393-1412. PubMed ID: 33539598
[TBL] [Abstract][Full Text] [Related]
10. The Alzheimer's disease-protective CD33 splice variant mediates adaptive loss of function via diversion to an intracellular pool.
Siddiqui SS; Springer SA; Verhagen A; Sundaramurthy V; Alisson-Silva F; Jiang W; Ghosh P; Varki A
J Biol Chem; 2017 Sep; 292(37):15312-15320. PubMed ID: 28747436
[TBL] [Abstract][Full Text] [Related]
11. CD33 isoforms in microglia and Alzheimer's disease: Friend and foe.
Eskandari-Sedighi G; Jung J; Macauley MS
Mol Aspects Med; 2023 Apr; 90():101111. PubMed ID: 35940942
[TBL] [Abstract][Full Text] [Related]
12. CD33 in Alzheimer's Disease - Biology, Pathogenesis, and Therapeutics: A Mini-Review.
Zhao L
Gerontology; 2019; 65(4):323-331. PubMed ID: 30541012
[TBL] [Abstract][Full Text] [Related]
13. Association of CD33 and MS4A cluster variants with Alzheimer's disease in East Asian populations.
Mao YF; Guo ZY; Pu JL; Chen YX; Zhang BR
Neurosci Lett; 2015 Nov; 609():235-9. PubMed ID: 26455864
[TBL] [Abstract][Full Text] [Related]
14. SRSF1 and PTBP1 Are
van Bergeijk P; Seneviratne U; Aparicio-Prat E; Stanton R; Hasson SA
Mol Cell Biol; 2019 Sep; 39(18):. PubMed ID: 31208978
[TBL] [Abstract][Full Text] [Related]
15. Does the CD33 rs3865444 Polymorphism Confer Susceptibility to Alzheimer's Disease?
Siokas V; Aslanidou P; Aloizou AM; Peristeri E; Stamati P; Liampas I; Arseniou S; Drakoulis N; Aschner M; Tsatsakis A; Mitsias PD; Bogdanos DP; Hadjigeorgiou GM; Dardiotis E
J Mol Neurosci; 2020 Jun; 70(6):851-860. PubMed ID: 32088842
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy for Alzheimer's disease targeting CD33 reduces amyloid beta accumulation and neuroinflammation.
Griciuc A; Federico AN; Natasan J; Forte AM; McGinty D; Nguyen H; Volak A; LeRoy S; Gandhi S; Lerner EP; Hudry E; Tanzi RE; Maguire CA
Hum Mol Genet; 2020 Oct; 29(17):2920-2935. PubMed ID: 32803224
[TBL] [Abstract][Full Text] [Related]
17. Genetics of CD33 in Alzheimer's disease and acute myeloid leukemia.
Malik M; Chiles J; Xi HS; Medway C; Simpson J; Potluri S; Howard D; Liang Y; Paumi CM; Mukherjee S; Crane P; Younkin S; Fardo DW; Estus S
Hum Mol Genet; 2015 Jun; 24(12):3557-70. PubMed ID: 25762156
[TBL] [Abstract][Full Text] [Related]
18. TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer's Disease.
Griciuc A; Patel S; Federico AN; Choi SH; Innes BJ; Oram MK; Cereghetti G; McGinty D; Anselmo A; Sadreyev RI; Hickman SE; El Khoury J; Colonna M; Tanzi RE
Neuron; 2019 Sep; 103(5):820-835.e7. PubMed ID: 31301936
[TBL] [Abstract][Full Text] [Related]
19. Association of CD33 rs3865444:C˃A polymorphism with a reduced risk of late-onset Alzheimer's disease in Slovaks is limited to subjects carrying the APOE ε4 allele.
Javor J; Ďurmanová V; Párnická Z; Minárik G; Králová M; Pečeňák J; Vašečková B; Režnáková V; Šutovský S; Gmitterová K; Hromádka T; Peterajová Ľ; Shawkatová I
Int J Immunogenet; 2020 Oct; 47(5):397-405. PubMed ID: 32333488
[TBL] [Abstract][Full Text] [Related]
20. CD33M inhibits microglial phagocytosis, migration and proliferation, but the Alzheimer's disease-protective variant CD33m stimulates phagocytosis and proliferation, and inhibits adhesion.
Butler CA; Thornton P; Brown GC
J Neurochem; 2021 Jul; 158(2):297-310. PubMed ID: 33720433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
